| MOSNX | VTIAX | MOSNX / VTIAX | |
| Total Expense Ratio | 1.49 | 0.09 | 1,656% |
| Annual Report Gross Expense Ratio | 1.62 | 0.09 | 1,800% |
| Fund Existence | 23 years | 16 years | - |
| Gain YTD | 2.273 | 14.651 | 16% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 273M | 629B | 0% |
| Annual Yield % from dividends | 2.22 | 2.63 | 84% |
| Returns for 1 year | -5.55 | 29.03 | -19% |
| Returns for 3 years | 9.16 | 59.48 | 15% |
| Returns for 5 years | -11.35 | 35.27 | -32% |
| Returns for 10 years | 29.21 | 104.40 | 28% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AFK | 27.68 | 0.20 | +0.73% |
| VanEck Africa ETF | |||
| LVHD | 42.22 | 0.27 | +0.65% |
| Franklin U.S. Low Volatility Hi Div ETF | |||
| PFUT | 26.58 | 0.16 | +0.61% |
| Putnam Sustainable Future ETF | |||
| CRSH | 20.94 | -0.20 | -0.96% |
| Yieldmax Short Tsla Option Income Strategy ETF | |||
| XBI | 127.76 | -5.86 | -4.39% |
| State Street® SPDR® S&P® Biotech ETF | |||